Nutrition Care Nalgestic Ultra is a fast, safe and effective all natural COX – 2 inhibitor designed to effectively target muscular aches and pains, inflammation and arthritis.
Each tablet is twice s strong as Nalgestic Forte, and contains Cumerone¶© which has been specially blended and developed for superior absorption, resulting in greater efficacy and rapid onset of action.
Nutrition Care Nalgestic Ultra has a clinically proven two way effect – it inhibits factors that cause cartilage degeneration and provides symptomatic relief of pain and inflammation.
A premium extract of curcumin from Curcuma longa (Turmeric) featuring fast-acting Cumerone¶© to effectively assist in the relief of symptoms and other inflammatory conditions
The superior clinical efficacy of Nutrition Care Nalgestic Ultra is due to a unique extraction process, which ensures a high yield of curcuminoids. These active principles are then blended as Cumerone¶© to significantly improve bioavailability, increasing absorption and ensuring a rapid onset of action.
- Temporary relief of arthritic pain
- Temporary relief of the pain of rheumatoid arthritis
- Temporary relief of the pain of osteoarthritis
- Relief of muscular aches and pains
- Temporary relief of rheumatic pain
- May reduce joint inflammation
- May assist in the management of osteoarthritic pain
- May assist in reducing joint stiffness and swelling
Each tablet contains:
- Cumerone 121.48 mg
Total Curcumin 12.148 mg
Adults: One tablet daily with a glass of water.
For acute purposes, up to three tablets per day can be taken, or as directed by a qualified healthcare practitioner.
Not to be given to children four years of age and under.
The anti-arthritis activity of curcumin has been established with a double-blind cross over trial performed on 18 patients suffering from diagnosed rheumatoid arthritis. They showed significant improvement of symptoms (duration of morning stiffness, walking time and joint swelling) after administration of curcumin. Curcumin was given at a dose of 1200mg/day for five to six weeks. Significant improvement was observed in all patients.
A study in 182 patients with rheumatoid arthritis and joint swelling showed a significant inter-group difference at the end of the 16 weeks of therapy.
In another trial it was demonstrated that Curcumin had an anti-inflammatory effect and assisted in the reduction of stiffness and joint swelling. 
In a randomized placebo-controlled double-blind trial in 45 patients with postoperative inflammation, the anti-inflammatory properties of curcumin were evaluated. Curcumin was found to be more effective than phenylbutazone in reducing tenderness and pain at operative site.
A review of five human trials published in the Journal of Alternative and Complementary Medicine in 2003, showed that in doses of 1125 – 2500mg, curcumin was safe and displayed evidence of anti-inflammatory activity.
Human trials using 1125-3500 mg of curcumin daily have found it to be safe.
The German Commission E monograph reports that curcumin should only be used after seeking professional medical advice if gallstones are present.
Contraindicated in pregnancy and lactation, as the safety of therapeutic doses of curcumin has not been established.
In theory, high-dose curcumin may increase the risk of bleeding when used concomitantly with anticoagulant drugs, so caution is advised.